ArticleArchives of virology2026
Identification of a capsid-derived Zika virus epitope with high IgG discriminatory performance.
Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The identification of specific serological targets for Orthoflavivirus zikaense (ZIKV) remains challenging due to the high degree of structural similarity and antibody cross-reactivity among co-circulating arboviruses, particularly dengue virus (DENV). In this context, immunoinformatics-based approaches may contribute to the rational selection of candidate epitopes with potentially improved analytical specificity. In the present study, five conserved ZIKV peptides previously identified through an immunoinformatic pipeline were experimentally evaluated as candidate serological targets. Peptide reactivity was assessed by indirect ELISA using human serum samples positive for anti-ZIKV IgM and IgG antibodies. Distinct reactivity patterns were observed between antibody classes. IgM assays showed limited analytical discriminatory capacity, particularly due to reduced specificity for some peptides. In contrast, IgG-based analyses revealed more favorable analytical profiles. Among the peptides evaluated, a peptide identified in the capsid (PEP03) exhibited the most favorable analytical performance, with an area under the ROC curve (AUC) of 0.9183 (95% CI: 0.8301-1.000). An absence of detectable reactivity was observed among sera from DENV-positive patients, and minimal reactivity with chikungunya virus (CHIKV) positive samples under the experimental conditions employed. Other peptides tested in this study demonstrated variable analytical profiles, reinforcing the importance of rational epitope selection for serological applications. Overall, these findings provide preliminary analytical evidence that structurally derived ZIKV epitopes may exhibit distinct IgM and IgG recognition patterns and support the continued evaluation of capsid-derived epitopes as candidate targets for serological applications (IgG detection) in regions where multiple arboviruses co-circulate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.